{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:04:22Z","timestamp":1788815062223,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.iac.2026.01.013","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T12:32:09Z","timestamp":1772627529000},"page":"347-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel Epinephrine Delivery Devices"],"prefix":"10.1016","volume":"46","author":[{"given":"Nicole O\u2019.","family":"Malley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay Adam","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib1","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2025.01.021","article-title":"Anaphylaxis definition, overview, and clinical support tool: 2024 consensus report-a GA(2)LEN project","volume":"156","author":"Dribin","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.01.013_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.anai.2015.07.019","article-title":"Anaphylaxis--a practice parameter update 2015","volume":"115","author":"Lieberman","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.01.013_bib3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jaci.2020.01.017","article-title":"Anaphylaxis-a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis","volume":"145","author":"Shaker","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.iac.2026.01.013_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World allergy organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","article-title":"Anaphylaxis: a 2023 practice parameter update","volume":"132","author":"Golden","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.01.013_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/ACI.0000000000001009","article-title":"Evidence-based use of epinephrine in anaphylaxis","volume":"24","author":"Hammond","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.01.013_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1067\/mai.2001.119916","article-title":"Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule\/syringe\/needle method practical?","volume":"108","author":"Simons","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.01.013_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cea.14565","article-title":"Adrenaline auto-injectors for preventing fatal anaphylaxis","volume":"55","author":"Sim","year":"2025","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.anai.2013.06.002","article-title":"Bioavailability of epinephrine from Auvi-Q compared with EpiPen","volume":"111","author":"Edwards","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.12.034","article-title":"Epinephrine autoinjectors prescriptions are not filled due to dislike of needles: results of a patient survey","volume":"151","author":"Kaplan","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2026.01.013_bib12","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/all.12262","article-title":"A majority of parents of children with peanut allergy fear using the epinephrine auto-injector","volume":"68","author":"Chad","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2023.11.267","article-title":"Effect of needle-free epinephrine on food allergy patient and caregiver quality of life","volume":"153","author":"Kafal","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.01.013_bib14","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jaip.2018.04.006","article-title":"Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature","volume":"6","author":"Shaker","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2019.12.859","article-title":"The effects of heating on EpiPen epinephrine auto-injector device integrity and function","volume":"145","author":"Agosti","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.01.013_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anai.2016.04.006","article-title":"A systematic review of epinephrine degradation with exposure to excessive heat or cold","volume":"117","author":"Parish","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s11606-022-07694-z","article-title":"Out-of-Pocket spending on epinephrine auto-injectors among the privately insured, 2015-2019","volume":"38","author":"Chua","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"5","key":"10.1016\/j.iac.2026.01.013_bib18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1081-1206(10)61129-5","article-title":"Lack of worldwide availability of epinephrine autoinjectors for outpatients at risk of anaphylaxis","volume":"94","author":"Simons","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2026.01.013_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010024","article-title":"Epinephrine in anaphylaxis: preclinical study of pharmacokinetics after sublingual administration of taste-masked tablets for potential pediatric use","volume":"10","author":"Rachid","year":"2018","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaci.2005.12.1310","article-title":"Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis","volume":"117","author":"Rawas-Qalaji","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.01.013_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16060811","article-title":"Development of neffy, an epinephrine nasal spray, for severe allergic reactions","volume":"16","author":"Ellis","year":"2024","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.iac.2026.01.013_bib24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.anai.2022.10.024","article-title":"Pharmacokinetic and pharmacodynamic comparison of epinephrine, administered intranasally and intramuscularly: an integrated analysis","volume":"130","author":"Tanimoto","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.01.013_bib25","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jaci.2023.08.007","article-title":"Pharmacokinetics\/pharmacodynamics of epinephrine after single and repeat administration of neffy, EpiPen, and manual intramuscular injection","volume":"152","author":"Casale","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib26","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaip.2023.11.006","article-title":"Adult pharmacokinetics of self-administration of epinephrine nasal spray 2.0 mg versus manual intramuscular epinephrine 0.3 mg by health care provider","volume":"12","author":"Casale","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"10.1016\/j.iac.2026.01.013_bib27","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jaip.2024.02.038","article-title":"Upper respiratory tract infections have minimal impact on neffy\u2019s pharmacokinetics or pharmacodynamics","volume":"12","author":"Oppenheimer","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2026.01.013_bib28","article-title":"The impact of anaphylaxis on the absorption of intranasal epinephrine in anaesthetized non-naive beagle dogs","volume":"2","author":"Sparapani","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"6, Supplement","key":"10.1016\/j.iac.2026.01.013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2024.08.227","article-title":"Pharmacokinetics and pharmacodynamics following repeat dosing of epinephrine nasal spray versus intramuscular injection during allergic rhinitis","volume":"133","author":"Oppenheimer","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib30","doi-asserted-by":"crossref","first-page":"AB93","DOI":"10.1016\/j.jaci.2024.12.295","article-title":"Pharmacokinetics of epinephrine nasal spray under various conditions","volume":"155","author":"Fleischer","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2026.01.013_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaip.2025.03.019","article-title":"Pharmacokinetics and pharmacodynamics of neffy, epinephrine nasal spray, in pediatric allergy patients","volume":"13","author":"Fleischer","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib32","doi-asserted-by":"crossref","first-page":"AB371","DOI":"10.1016\/j.jaci.2023.11.888","article-title":"Neffy, epinephrine nasal spray, demonstrates a positive efficacy and safety profile for the treatment of allergic reactions in pediatric patients at-Risk of anaphylaxis: phase 3 study results","volume":"153","author":"Ebisawa","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.iac.2026.01.013_bib33","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.jaip.2024.10.006","article-title":"Pharmacokinetic and pharmacodynamic profile of epinephrine nasal spray versus intramuscular epinephrine autoinjector in healthy adults","volume":"12","author":"Greenhawt","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.anai.2024.04.033","article-title":"Randomized trial of pharmacokinetic and pharmacodynamic effects of 13.2 mg intranasal epinephrine treatment in congestion","volume":"133","author":"Dworaczyk","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.iac.2026.01.013_bib35","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.jaip.2023.06.044","article-title":"Fast acting, dry powder, needle-free, intranasal epinephrine spray: a promising future treatment for anaphylaxis","volume":"11","author":"Tal","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.iac.2026.01.013_bib36","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.anai.2025.01.006","article-title":"Integrated phase I pharmacokinetics and pharmacodynamics of epinephrine administered through sublingual film, autoinjector, or manual injection","volume":"134","author":"Kraus","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.12.013","article-title":"Impact of food exposure on the pharmacokinetics of epinephrine sublingual film","volume":"151","author":"Oppenheimer","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2024.12.298","article-title":"Fast acting, 5 years stable intra-nasal powder-spray epinephrine for anaphylaxis: integrated analysis of two clinical trials","volume":"155","author":"Lapidot","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2024.12.310","article-title":"Stability results of AnaphylmTM (Epinephrine sublingual film) under extreme temperature conditions","volume":"155","author":"Varjan","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib40","doi-asserted-by":"crossref","first-page":"AB367","DOI":"10.1016\/j.jaci.2023.11.877","article-title":"Bioavailability and stability of an epinephrine nasal powder formulation for treatment of anaphylaxis","volume":"153","author":"J\u00f6nsson","year":"2024","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2026.01.013_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2023.11.887","article-title":"Comparative stability of three epinephrine products under extreme temperature conditions","volume":"153","author":"Lowenthal","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:31:28Z","timestamp":1776349888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856126000135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0889856126000135"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2026.01.013","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Epinephrine Delivery Devices","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2026.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}